Mucosal Melanoma
📧 Sign up to get email alerts when something new happens for Mucosal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with bevacizumab or ipilimumab as first-line therapy in patients with unresectable stage IV melanoma…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma [Phase 2]
Phase II clinical trial update for advanced mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. [Phase 2]
Phase 2 trial update evaluating the combination of CM082 with JS001 in patients with advanced mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Apatinib Plus SHR1210 in Advanced Mucosal Melanoma [Phase 2]
Phase 2 trial evaluating apatinib plus SHR1210 in advanced mucosal melanoma; currently status unknown.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma [Phase 2]
Phase 2 study evaluating epacadostat with a vaccine therapy in patients with stage III-IV melanoma has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread [Phase 2]
A completed Phase 2 trial evaluated nilotinib for metastatic acral lentiginous melanoma and mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating bevacizumab in combination with carboplatin and paclitaxel for metastatic mucosal melanoma.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma [Phase 2]
Phase 2 trial results for SU011248 in metastatic mucosal melanoma and acral lentiginous melanoma; the study is completed and results were po…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma [Phase 2]
Phase 2 clinical trial evaluating imatinib in mucosal melanoma, acral lentiginous melanoma, and chronically sun-damaged melanomas. The study…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma [Phase 2]
Phase 2 trial evaluating nilotinib in patients with metastatic mucosal, acral, or chronically sun-damaged melanoma who are resistant or into…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma [Phase 2]
Phase 2 trial of dasatinib in acral lentiginous, mucosal, or chronic sun-damaged melanoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma [Phase 2]
A Phase 2 vaccine therapy trial in melanoma patients with Stage IIC to IV disease has completed. The trial encompassed intraocular subtypes …
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV [Phase 2]
A Phase 2 study evaluating the combination of temsirolimus and AZD6244 (selumetinib) in treatment-naive patients with BRAF-mutant unresectab…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with or without sorafenib tosylate in patients with unresectable stage III or stage IV m…